Abstracts

1064 – Changes in Suicidality, Depression, and Anxiety After Integrative Mental Health Care in Thai Youth

Background This study aimed to assess suicidality, depression, and anxiety following the introduction of integrative mental health care into HIV services for Thai youth living with HIV (YLHIV). Methods A multicenter prospective cohort study was conducted among YLHIV (aged 15-24 years) and age and sex-matched HIV-negative youth in Thailand. Participants were assessed for suicidality, depression…

1058 – Enhanced Adherence Counselling Among Adolescents With Detectable Viremia in Cameroon

Background In low-and middle-income countries (LMIC), mortality among adolescents living with HIV(ADLHIV) is still concerning, driven by poor viral suppression(VS) in the frame of limited adherence monitoring approaches. We herein evaluated the virological outcomes after enhanced adherence counselling (EAC) among ADLHIV with non-VS and low-level viremia (LLV) in the era of tenofovir-lamivudine-dolutegravir (TLD) in Cameroon.…

1069 – Left Ventricular Mass Adjustment for Body Size in Youth With Perinatal HIV or Perinatal HIV Exposure

Background Cardiac-related complications were one of the most common causes of death in youth living with perinatally-acquired HIV (YPHIV) prior to widespread ART. However, diagnosing Left Ventricular Hypertrophy (LVH) typically relies on indices based on allometric exponents estimated from adults, which normalize Left Ventricular Mass (LVM) by body surface area (BSA) or height (HT) raised to…

1057 – HIV-1 Drug Resistance at Low- and High-Level Viremia in Kenyan Youth on Dolutegravir-Based Therapy

Background Understanding of the extent and patterns of HIV-1 drug resistance in the era of globally widespread dolutegravir therapy is limited, particularly for youth. Data on low-level viremia (LLV; 200-1,000 copies/mL) are sparse, primarily due to technical difficulties with genotyping at low RNA levels, and the evolving global definitions of treatment failure. Methods We developed…

407 – HIV-Specific T & Humoral Response: Data From the First Pediatric Combined Therapeutic Vaccine Trial

Background Therapeutic vaccines offer a promising approach to decrease HIV reservoirs, enhance immunity and enable ART-free remission. This study characterizes HIV-specific T and humoral responses following prime-boost vaccination of the HVRRICANE trial: HIVIS DNA and MVA-CMDR vaccines ± the TLR4 agonist with Cervarix HPV vaccine co-administration. Methods HVRRICANE enrolled 25 South African adolescents with perinatal HIV, virally…

1039 – Distinct Innate Immune-Driven TNFa Pathway Is Linked With Durable ART-Free Aviremia in Pediatric HIV

Background Mechanisms underlying sustained ART-free HIV cure/remission remain elusive. Very-early ART-treated children LWH after vertical transmission may have a high potential for cure/remission due to the tolerogenicity of early life immunity. We here evaluate a group of children LWH maintaining ART-free undetectable levels of HIV viral RNA and DNA termed “ putative cure” children. Previous publications…

1032 – Evolving Expression of Co-Inhibitory Receptors and Plasma Cytokines in Children Living With HIV

Background HIV disease in children differs from that seen in adults. The objective of this study was to test the association between HIV reservoir size and the development of antiviral immunity between childhood, adolescence and young adulthood in terms of a) expression of co-inhibitory receptors; and b) expression of plasma cytokines.  Methods Expression of co-inhibitory…

1048 – Alternative Dosing of ABC/3TC Dispersible Tablets to Align With Dolutegravir Dosing in Neonates

Background Rapid maturation of metabolic/elimination pathways during the first month of life complicates using pediatric fixed-dose dispersible formulations in neonates. We previously reported that once daily administration of abacavir/lamivudine dispersible tablets (ABC/3TC-DT) to neonates gave high exposure during the first week of life. Administration of 5 mg dolutegravir (DTG) every 48 hours (q48) for the…

940 – Plasma Biomarkers in Children and Young People With Long COVID

Background Although most patients infected with SARS-CoV-2 recover, 10-20% can develop long-term persistent symptoms after the acute infection, a condition known as long COVID or Post-Acute Sequalae of SARS-CoV-2 (PASC). In this study we aim to compare autoantibodies, cytokines and  neuronal and vascular damage biomarkers in plasma from  children and young people (CYP) with and…

1024 – Obesity and Metabolic Comorbidities in Young Adults With Perinatal HIV Exposure Without Infection

Background The global scale-up of prenatal antiretroviral therapy (ART) has reduced the vertical transmission of HIV to <1%. In this context, a growing population of individuals with perinatal HIV exposure without infection (PHEU) has emerged, which now exceeds 20 million people worldwide. While growing evidence indicates that infants and children with PHEU are at increased…